URTUrteste S.A.Partial data
43.60PLN-2.24%Mkt Cap: 16.85M $P/E:

Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus…